Inhibrx Biosciences (INBX) Receivables - Other: 2023-2025
- Inhibrx Biosciences' Receivables - Other was N/A to $727,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $727,000, marking a year-over-year change of. This contributed to the annual value of $41,000 for FY2024, which is 93.25% down from last year.
- Per Inhibrx Biosciences' latest filing, its Receivables - Other stood at $727,000 for Q3 2025, which was down 0.41% from $730,000 recorded in Q2 2025.
- Inhibrx Biosciences' 5-year Receivables - Other high stood at $952,000 for Q2 2024, and its period low was $41,000 during Q4 2024.
- In the last 3 years, Inhibrx Biosciences' Receivables - Other had a median value of $727,000 in 2025 and averaged $611,400.
- Data for Inhibrx Biosciences' Receivables - Other shows a maximum YoY plummeted of 93.25% (in 2024) over the last 5 years.
- Quarterly analysis of 3 years shows Inhibrx Biosciences' Receivables - Other stood at $607,000 in 2023, then plummeted by 93.25% to $41,000 in 2024, then decreased by 23.32% to $727,000 in 2025.
- Its Receivables - Other stands at $727,000 for Q3 2025, versus $730,000 for Q2 2025 and $41,000 for Q4 2024.
